Serum microRNA-122 kinetics in patients with chronic hepatitis C virus infection during antiviral therapy

Journal of Viral Hepatitis

Volumn 20, Issue 8, 2013, Pages 530-535

  Koberle V ^a   Waidmann, O ^a   Kronenberger, B ^a   Andrei, A ^a   Susser, S ^a   Fuller C ^a   Perner, D ^a   Zeuzem, S ^a   Sarrazin, C ^a   Piiper, A ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

circulating miRNA; hepatitis C virus; interferon; miR 122; response to therapy

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; INTERLEUKIN 28B; MICRORNA 122; MICRORNA 16; PEGINTERFERON; RIBAVIRIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; FOLLOW UP; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RELAPSE; RETROSPECTIVE STUDY; TREATMENT DURATION; TREATMENT RESPONSE; VIRUS LOAD;

CIRCULATING MIRNA; HEPATITIS C VIRUS; INTERFERON; MIR-122; RESPONSE TO THERAPY;

ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER; MALE; MICRORNAS; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; RIBAVIRIN; RNA, VIRAL; SERUM;

EID: 84879800115     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12075     Document Type: Article

References (28)

1. Mitchell PS, Parkin RK, Kroh EM, et al,. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 2008; 105: 10513-10518.
2. Wang K, Zhang S, Marzolf B, et al,. Circulating microRNAs, potential biomarkers from drug-induced liver injury. Proc Natl Acad Sci USA 2009; 106: 4402-4407.
3. Zhang Y, Jia Y, Zheng R, et al,. Plasma microRNA-122 as a biomarker for viral-, alcohol-, and chemical-related hepatic diseases. Clin Chem 2010; 56: 1830-1838.
4. Xu J, Wu C, Che X, et al,. Circulating microRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis. Mol Carcinog 2011; 50: 136-142.
5. Bihrer V, Friedrich-Rust M, Kronenberger B, et al,. A. Serum miR-122 as a biomarker of necroinflammation in patients with chronic hepatitis C virus infection. Am J Gastroenterol 2011; 106: 1663-1669.
6. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L,. Circulating microRNAs in patients with chronic hepatitis C and non-alcoholic fatty liver disease. PLoS ONE 2011; 6: e23937.
7. Starkey Lewis PJ, Dear J, Platt V, et al,. Circulating microRNAs as potential markers of human drug-induced liver injury. Hepatology 2011; 54: 1767-1776.
8. Waidmann O, Bihrer V, Pleli T, et al,. Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection. J Viral Hepat 2012; 19: e58-e65.
9. Arroyo JD, Chevillet JR, Kroh EM, et al,. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci USA 2011; 108: 5003-5008.
10. Kogure T, Lin WL, Yan IK, Braconi C, Patel T,. Intercellular nanovesicle-mediated microRNA transfer: a mechanism of environmental modulation of hepatocellular cancer cell growth. Hepatology 2011; 54: 1237-1248.
11. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, Lendeckel W, Tuschl T,. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002; 12: 735-739.
12. Chang J, Nicolas E, Marks D, et al,. miR-122, a mammalian liver-specific microRNA, is processed from hcr mRNA and may downregulate the high affinity cationic amino acid transporter CAT-1. RNA Biol 2004; 1: 106-113.
13. Krützfeldt J, Rajewsky N, Braich R, et al,. Silencing of microRNAs in vivo with 'antagomirs'. Nature 2005; 438: 685-689.
14. Esau C, Davis S, Murray SF, et al,. miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab 2006; 3: 87-98.
15. Jopling CL, Yi M, Lancaster AM, Lemon SM, Sarnow P,. Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA. Science 2005; 309: 1577-1581.
16. Shan Y, Zheng J, Lambrecht RW, Bonkovsky HL,. Reciprocal effects of micro-RNA-122 on expression of heme oxygenase-1 and hepatitis C virus genes in human hepatocytes. Gastroenterology 2007; 133: 1166-1174.
17. Lin CJ, Gong HY, Tseng HC, Wang WL, Wu JL,. miR-122 targets an anti-apoptotic gene, Bcl-w, in human hepatocellular carcinoma cell lines. Biochem Biophys Res Commun 2008; 375: 315-320.
18. Tsai WC, Hsu PW, Lai TC, et al,. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2009; 49: 1571-1582.
19. Lanford RE, Hildebrandt-Eriksen ES, Petri A, et al,. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010; 327: 198-201.
20. Laterza OF, Lim L, Garrett-Engele PW, et al,. Plasma microRNAs as sensitive and specific biomarkers of tissue injury. Clin Chem 2009; 55: 1977-1983.
21. Sarrazin C, Schwendy S, Möller B, et al,. Improved responses to pegylated interferon alfa-2b and ribavirin by individualizing treatment for 24-72 weeks. Gastroenterology 2011; 141: 1656-1664.
22. Waidmann O, Bihrer V, Kronenberger B, Zeuzem S, Piiper A, Forestier N,. Pretreatment serum microRNA-122 is not predictive for treatment response in chronic hepatitis C virus infection. Dig Liver Dis 2012; 44: 438-441.
23. Wang K, Zhang S, Weber J, Baxter D, Galas DJ,. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 2010; 38: 7248-7259.
24. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y, Iwai N,. Plasma miR-208 as a biomarker of myocardial injury. Clin Chem 2009; 55: 1944-1949.
25. Skog J, Würdinger T, van Rijn S, et al,. Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers. Nat Cell Biol 2008; 10: 1470-1476.
26. Waidmann O, Köberle V, Brunner F, Zeuzem S, Piiper A, Kronenberger B,. Serum microRNA-122 predicts survival in patients with liver cirrhosis. PLoS ONE 2012; 7: e45652.
27. van der Meer AJ, Farid WRR, Sonneveld MJ, et al,. Sensitive detection of hepatocellular injury in chronic hepatitis C patients with circulating hepatocyte-derived microRNA-122. J Viral Hepat 2013; 20: 158-166.
28. Sarasin-Filipowicz M, Krol J, Markiewicz I, Heim MH, Filipowicz W., Decreased levels of microRNA miR-122 in individuals with hepatitis C responding poorly to interferon therapy. Nat Med 2009; 15: 31-33.